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Abstract Hypothalamic GnRH (GnRH-I) is known and named
for its role in regulating reproductive function in vertebrates by
controlling release of gonadotropins from the pituitary. However,
another form of GnRH of unknown function (pGlu-His-Trp-Ser-
His-Gly-Trp-Tyr-Pro-Gly; GnRH-II) is expressed in the mes-
encephalon of all vertebrate classes except jawless fish. Here we
show with immunocytochemical staining that the GnRH-II
peptide is localized to the mouse midbrain as in other vertebrates,
as well as in cells surrounding the ventricles and in cells adjacent
to the hippocampus. Staining of adjacent sections using GnRH-I
antibody revealed that the distribution of GnRH-I does not
overlap with that of GnRH-II.
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1. Introduction
Hypothalamic GnRH (GnRH-I) is the ¢rst in a cascade of
hormones that regulates reproductive function in all verte-
brates. Synthesized and secreted by neuroendocrine cells in
the preoptic area of the hypothalamus, GnRH signals the
anterior pituitary to release the gonadotropins that trigger
sex hormone secretion and gametogenesis in the gonads.
Although hypothalamic GnRH is the most studied, there
are two other GnRH peptide forms that have been localized
to di¡erent regions of the brain [1]. All known GnRH variants
are comprised of ten amino acids: positions 1, 4, 9, and 10 are
invariant, but positions 5 through 8 are highly variable [1].
Although GnRH-III (pGlu-His-Trp-Ser-Try-Gly-Trp-Leu-
Pro-Gly; bold residues indicate di¡erences from GnRH-I)
has only been identi¢ed in ¢sh [2], GnRH-II (pGlu-His-Trp-
Ser-His-Gly-Trp-Tyr-Pro-Gly) has been found in all verte-
brate classes except jawless ¢shes and has been localized to
the mesencephalon in every species in which it has been
studied [1]. GnRH-II was thought not to exist in placental
mammals [3], but now its cDNA has been cloned and local-
ized in several mammals including the tree shrew (Tupaia glis)
[1], humans [4], and rhesus monkey [5].
Although the function of GnRH-II is unknown, its neuro-
anatomical distribution suggests that it has a physiological
function distinct from that of GnRH-I. Immunocytochemical
studies of GnRH forms in ¢sh, amphibians, reptiles, birds,
and mammals have consistently found that GnRH-II predom-
inates in the posterior brain regions, while GnRH-I is usually
limited to forebrain structures including the hypothalamus
[1,6]. For example, using immunocytochemistry in the musk
shrew (Suncus murinus), Rissman et al. [7] found no overlap in
either the distribution of neurons containing GnRH-II and
GnRH-I or in the projection sites of these neurons, primarily
the median eminence and the medial habenula, respectively.
Using both immunocytochemistry and in situ hybridization in
the tree shrew, Kasten et al. [1] also found no overlap in the
distribution of neurons containing the two forms of GnRH.
In the rhesus macaque, immunocytochemical staining revealed
a posterior system of neurons containing GnRH-II that proj-
ects throughout the brain to structures including the hind-
brain, posterior pituitary, and spinal cord, and an anterior
system of neurons containing GnRH-I which project from
the hypothalamus to the pituitary or median eminence [8].
Urbanski et al. [5] used cRNA probes in the rhesus macaque
to identify GnRH-II-expressing neurons in the midbrain, hip-
pocampus, and several regions of the hypothalamus. How-
ever, the hypothalamic distribution of GnRH-II-expressing
neurons did not overlap with that of GnRH-I-expressing neu-
rons.
Neurons expressing these two forms of GnRH have strik-
ingly di¡erent ontogenies, in addition to the di¡erences in
their distributions. GnRH-I-containing neurons originate in
the olfactory placode and migrate to the preoptic area of
the hypothalamus during development [3,9,10] whereas
GnRH-II neurons originate within the mesencephalon [5].
Although GnRH-II has been isolated in every taxonomic
class of jawed vertebrates, it was long thought not to exist in
rodents [8]. Because GnRH-II peptide has been identi¢ed both
in species which evolved more recently than rodents (such as
primates) and in classes which predate rodents (e.g. ¢sh, am-
phibians, reptiles, and birds), it seems highly unlikely that
GnRH-II is not present in rodents, especially since a recent
phylogenetic analysis [4] suggests that the multiple GnRH iso-
forms arose from a gene duplication event that preceded the
appearance of vertebrates. In fact, it was recently shown that
a peptide from mouse brain coelutes with GnRH-II using high
pressure liquid chromatography and also has GnRH-II-like
immunoreactivity [11]. Here we reexamine the presence of
GnRH-II throughout the mouse brain using immunocyto-
chemistry.
2. Materials and methods
Nine-month-old adult male mice (progeny of a B10.AUB10.BR F2
cross) were anesthetized with CO2, perfused with 4.0% paraformalde-
hyde in PBS, and killed, all in accordance with guidelines of the
Stanford University Administrative Panel on Laboratory Animal
Care. The brains were post¢xed for 5 h at room temperature and
then overnight at 4‡C, followed by embedding in agar, equilibration
in 30% sucrose, and freezing in Tissue Tek O.C.T. medium (Sakura
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Finetek, Torrence, CA). Each brain was cut coronally or sagittally
into two sets of alternate 50 Wm sections. The sections were rehy-
drated in PBS (four washes, 15 min each) and soaked in 3.0% hydro-
gen peroxide in PBS for 30 min to reduce endogenous peroxidase
activity. The sections were again washed with PBS as above and
blocked with 1.0% goat serum in PBT (0.2% BSA and 0.2% Triton
X-100 in PBS) for 2 h to decrease non-speci¢c background staining.
Sections were incubated for 40 h at 4‡C with GnRH-II polyclonal
antiserum raised in rabbit (anti-cGnRH-II, Lot aCII6) [12,13] diluted
5000-fold in PBT containing 1.0% goat serum.
As controls for the speci¢city of the staining, in some cases alter-
nate sections were either: (a) exposed to the primary antibody solu-
tion without primary antibody, (b) exposed to primary antibody pre-
absorbed with 100 Wg GnRH-II peptide (American Peptide Company,
Sunnyvale, CA) per ml of antibody solution, or (c) incubated with
rabbit LHRH (GnRH-I) polyclonal antiserum (HU60) [14].
Sections were washed with PBT (four washes, 15 min each) and
incubated for 10 h at 4‡C with biotinylated goat anti-rabbit IgG
secondary antibody diluted to 0.5% in PBT, then washed again with
PBT and incubated with avidin-biotin-peroxidase complex (Vector
Laboratories, Burlingame, CA) for 3 h at room temperature, and
developed with 3,3P-diaminobenzidine (Sigma, St. Louis, MO) as
chromogen. The sections were dehydrated in ethanol and cleared in
xylene, mounted with Permount (Fisher Scienti¢c, Fair Lawn, NJ),
coverslipped, and examined using light microscopy.
3. Results
GnRH-II-immunopositive cells were located in areas sur-
rounding each of the cerebral ventricles along most of their
length: the lateral ventricles (Fig. 1A), third ventricle (dorsal
third ventricle shown in Fig. 1B), midbrain aqueduct (Fig.
1C), and fourth ventricle (Fig. 1D). The cells surrounding
the third ventricle (Fig. 1B) were located in the medial habe-
nula. GnRH-II-immunopositive cells were also identi¢ed
among neurons adjacent to the hippocampus (Fig. 1F). No
GnRH-II immunoreactivity was observed in the medial sep-
tum-diagonal band (Fig. 1E) or hypothalamus, sites where we
found extensive staining with GnRH-I (data not shown).
Staining was eliminated by omission of primary antibody
and preabsorption of the GnRH-II antiserum with GnRH-
II. GnRH-II-immunoreactive cells were smaller in size (V10
Wm in diameter) and more rounded in shape (Fig. 1, A^F)
than the cells which were immunoreactive for GnRH-I, which
were V20 Wm in diameter and had a more fusiform shape
(data not shown). All cells immunoreactive for GnRH-I or
GnRH-II were stained in the cytoplasm but not in the nu-
cleus. Immunoreactive processes of the GnRH-II-containing
cells were very short and thin, and were con¢ned to the same
brain regions as GnRH-II-immunoreactive cell bodies. In con-
trast, GnRH-I-immunoreactive axons were long (often s 250
Wm), and could easily be traced to other regions of the brain.
In sections exposed to the GnRH-I antiserum, immunopos-
itive cell bodies and processes were clearly identi¢ed in the
medial septum-diagonal band and the hypothalamus. No
cell bodies immunoreactive for GnRH-I were observed in
the periventricular regions found to contain GnRH-II immu-
noreactivity. However, ¢bers immunoreactive for GnRH-I
were identi¢ed in the areas surrounding the third ventricle,
the aqueduct, and the fourth ventricle (not shown).
4. Discussion
The di¡erential staining patterns produced by exposure to
the GnRH-I and GnRH-II antisera respectively indicate that
two distinct forms of GnRH exist in mouse and that these two
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Fig. 1. Coronal sections of mouse brain showing GnRH-II immunoreactivity. LV, lateral ventricle; 3V, dorsal third ventricle; MH, medial ha-
benula; AQ, aqueduct; 4V, fourth ventricle. Scale bar is 100 Wm. A: Lateral ventricle region. B: Dorsal third ventricle region (medial habenu-
la). C: Periaqueductal region. D: Fourth ventricle region. E: Medial septum-diagonal band. F: Tissue adjacent to hippocampus, near lateral
ventricle.
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forms exhibit distinct patterns of immunoreactivity in the
mouse brain. The morphology of the GnRH-II-immunopos-
itive cells identi¢ed in this study is consistent with that of
GnRH-II neurons previously identi¢ed in other species. In
rhesus macaque monkey, GnRH-I-immunopositive cells are
characteristically fusiform in shape with thick neurites and
the cells containing GnRH-II are smaller and more oval-
shaped, with ¢ne, short processes [8]. Our results are consis-
tent with these descriptions.
We found no evidence for the co-expression of GnRH-I and
GnRH-II in cells within the mouse brain. However, Chen et
al. [11] noted that a small number of cells in the mouse hy-
pothalamus showed immunoreactivity for GnRH-I and
GnRH-II. In the rhesus macaque, a recent study using the
highly sensitive method of RNA-RNA in situ hybridization
revealed no co-localization of GnRH-I and GnRH-II in the
brain, including the hypothalamus [5], in accord with our
results in the mouse using ICC. The limited evidence to date
suggests that the question of GnRH-I and GnRH-II co-ex-
pression requires further investigation.
Although no cell bodies immunopositive for GnRH-I were
identi¢ed in the regions surrounding the ventricles, ¢bers im-
munoreactive for GnRH-I were detected in these areas. This is
consistent with previous reports of GnRH-I-immunopositive
¢bers in the ventricular and subarachnoid spaces of the rat
brain. GnRH-I axons (but no cell bodies) have previously
been identi¢ed near the lateral ventricles, third ventricle, and
midbrain aqueduct of the rat brain, and some of these ¢bers
were shown to reach the ventricular cavity [15]. The only
GnRH-positive cell bodies we identi¢ed in periventricular re-
gions of the mouse brain were immunopositive for GnRH-II.
The function(s) of GnRH-II remain a mystery, but its iden-
ti¢cation and localization suggest some possibilities. The spa-
tial distribution is consistent with a neuromodulatory role, as
further supported by earlier functional analyses [16,17].
GnRH has also been implicated in immune system activity
based on several kinds of evidence: (a) the immunostimula-
tory e¡ects of GnRH-I [18], (b) high GnRH-II expression,
both in rhesus monkey spleen [5] and in human organs known
to contain large number of mast cells (e.g. kidney, prostate,
bone marrow) [4], (c) GnRH immunoreactivity in mast cells in
the ring dove medial habenula [19,20], and (d) the presence of
GnRH receptors in mouse thymus and spleen [18]. Likewise,
our ¢ndings indicate the presence of GnRH-II in areas asso-
ciated with mast cell function, because in the mouse, mast
cells are located along the vasculature associated with the
hippocampus and the lateral and third ventricles [21].
Although immunocytochemical, behavioral, and expression
studies have provided important clues as to the distribution
and possible sites of action of GnRH-II, the crucial steps in
gaining a clearer picture of its physiological function will be
the targeted deletion of the gene for GnRH-II in mouse and
subsequent studies of mice lacking a functional GnRH-II
gene.
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